After a judgment against Bayer in a glyphosate-process the company's shares slumped. The paper of the group crashed at the Opening of the Frankfurt stock exchange in the Morning by more than ten percent.
The market responded to a message from the USA: There, the chemical company Bayer had lost an important part of the process to the alleged cancer risks of products of the subsidiaries of Monsanto. A Jury of the competent Federal district court in San Francisco ruled on Tuesday unanimously that the weed killer Roundup with the controversial active ingredient glyphosate glands is a key factor for the lymphatic cancer has been the disease of the plaintiff, Edwin Hardeman.
Thus, the process is now in a second Phase, to clarify, whether or not Monsanto deceived about the risks and the possible damages could be.
To Bayer, this case is highly controversial, because it is a Bellwether Case. Thus, a kind of pattern case in US law in a mass procedure. Several of these representative cases are reported. They should help the parties to the dispute, to the extent of damage and the amount of possible payments of compensation better estimate.More about
USA glyphosate-process against Bayer, a subsidiary of Monsanto beginsHeike Jahberg daily mirror tomorrow location for Free order
Overall, the competent US judge Vince Chhabria several Hundred complaints from farmers, gardeners and consumers bundled. (dpa, AFP)